Human induced pluripotent stem cell (hiPSC)-derived ventricular cardiomyocytes provide a reliable in vitro
system for mechanistic analysis, as well as drug safety and efficacy screenings. This platform
can help improve our understanding of the underlying pathophysiological mechanisms of cardiac
disease and develop effective treatments.
Ncyte® vCardiomyocytes are fully functiona and a clinically relevant cellular model compatible with functional assays such as calcium-imaging, contractility force evaluations, and metabolic studies among others.